Literature DB >> 516668

Myasthenia gravis.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 516668      PMCID： PMC1238662     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  23 in total

1.  Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations.

Authors:  A G Engel; E H Lambert; F M Howard
Journal:  Mayo Clin Proc       Date:  1977-05       Impact factor: 7.616

2.  Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.

Authors:  P C Dau; J M Lindstrom; C K Cassel; E H Denys; E E Shev; L E Spitler
Journal:  N Engl J Med       Date:  1977-11-24       Impact factor: 91.245

Review 3.  Myasthenia gravis (second of two parts).

Authors:  D B Drachman
Journal:  N Engl J Med       Date:  1978-01-26       Impact factor: 91.245

4.  The effect of thoracic duct lymph drainage in myasthenia gravis.

Authors:  K Bergström; C Franksson; G Matell; G von Reis
Journal:  Eur Neurol       Date:  1973       Impact factor: 1.710

5.  Benefit from alternate-day prednisone in myasthenia gravis.

Authors:  J R Warmolts; W K Engel
Journal:  N Engl J Med       Date:  1972-01-06       Impact factor: 91.245

6.  Further studies on the specificity of presumed immune associations of myasthenia gravis and consideration of possible pathogenic implications.

Authors:  A J Strauss; C W Smith; G W Cage; H W van der Geld; D E McFarlin; M Barlow
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

7.  The value of thymectomy in myasthenia gravis: a computer-assisted matched study.

Authors:  J M Buckingham; F M Howard; P E Bernatz; W S Payne; E G Harrison; P C O'Brien; L H Weiland
Journal:  Ann Surg       Date:  1976-10       Impact factor: 12.969

8.  Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.

Authors:  J M Lindstrom; M E Seybold; V A Lennon; S Whittingham; D D Duane
Journal:  Neurology       Date:  1976-11       Impact factor: 9.910

9.  Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange.

Authors:  J Newsom-Davis; A J Pinching; A Vincent; S G Wilson
Journal:  Neurology       Date:  1978-03       Impact factor: 9.910

10.  Myasthenic immunoglobulin accelerates acetylcholine receptor degradation.

Authors:  I Kao; D B Drachman
Journal:  Science       Date:  1977-04-29       Impact factor: 47.728
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.